Targeting head and neck cancer epigenetics with CRISPR-dCas9: An emerging therapeutic approach. Elumalai P, Ezhilarasan D, Lakshmi T. Oral Oncol 2022;127:105801.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Elumalai P, Ezhilarasan D, Lakshmi T. Targeting head and neck cancer epigenetics with CRISPR-dCas9: An emerging therapeutic approach. Oral Oncol 2022;127:105801.
PMID: 35255281